Syntactic discriminative language model rerankers for statistical machine translation

This article describes a method that successfully exploits syntactic features for n-best translation candidate reranking using perceptrons. We motivate the utility of syntax by demonstrating the superior performance of parsers over n-gram language models in differentiating between Statistical Machine Translation output and human translations. Our approach uses discriminative language modelling to rerank the n-best translations generated by a statistical machine translation system. The performance is evaluated for Arabic-to-English translation using NIST’s MT-Eval benchmarks. While deep features extracted from parse trees do not consistently help, we show how features extracted from a shallow Part-of-Speech annotation layer outperform a competitive baseline and a state-of-the-art comparative reranking approach, leading to significant BLEU improvements on three different test sets

Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency

BACKGROUND: Remethylation defects are rare inherited disorders in which impaired remethylation of homocysteine to methionine leads to accumulation of homocysteine and perturbation of numerous methylation reactions. OBJECTIVE: To summarise clinical and biochemical characteristics of these severe disorders and to provide guidelines on diagnosis and management. DATA SOURCES: Review, evaluation and discussion of the medical literature (Medline, Cochrane databases) by a panel of experts on these rare diseases following the GRADE approach. KEY RECOMMENDATIONS: We strongly recommend measuring plasma total homocysteine in any patient presenting with the combination of neurological and/or visual and/or haematological symptoms, subacute spinal cord degeneration, atypical haemolytic uraemic syndrome or unexplained vascular thrombosis. We strongly recommend to initiate treatment with parenteral hydroxocobalamin without delay in any suspected remethylation disorder; it significantly improves survival and incidence of severe complications. We strongly recommend betaine treatment in individuals with MTHFR deficiency; it improves the outcome and prevents disease when given early